Statins narrow cholesterol and blood pressure gaps between obese and healthy-weight adults

A new study has found that among adults over the age of 40, the typical gaps in cholesterol levels and blood pressure between individuals with obesity and those of a healthy weight have largely vanished. Researchers reported that the convergence of these health markers is primarily linked to the widespread use of statin medications among the obese population, which appears to equalize cardiovascular risk profiles across weight categories.

The analysis also noted instances where participants with obesity exhibited more favorable cholesterol or blood pressure readings than their normal‑weight counterparts, suggesting that pharmacological management can offset some of the metabolic disadvantages associated with excess weight. The findings highlight the impact of medication adherence on cardiovascular health outcomes in middle‑aged and older adults, underscoring the importance of treatment strategies alongside lifestyle interventions.